214 related articles for article (PubMed ID: 24098480)
1. Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange.
Sitkiewicz E; Tarnowski K; Poznański J; Kulma M; Dadlez M
PLoS One; 2013; 8(10):e76353. PubMed ID: 24098480
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oligomerization of full-length RAGE by synergy of the interaction of its domains.
Moysa A; Hammerschmid D; Szczepanowski RH; Sobott F; Dadlez M
Sci Rep; 2019 Dec; 9(1):20332. PubMed ID: 31889156
[TBL] [Abstract][Full Text] [Related]
3. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.
Zong H; Madden A; Ward M; Mooney MH; Elliott CT; Stitt AW
J Biol Chem; 2010 Jul; 285(30):23137-46. PubMed ID: 20504772
[TBL] [Abstract][Full Text] [Related]
4. Binding of S100 proteins to RAGE: an update.
Leclerc E; Fritz G; Vetter SW; Heizmann CW
Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
[TBL] [Abstract][Full Text] [Related]
5. Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis.
Wei W; Lampe L; Park S; Vangara BS; Waldo GS; Cabantous S; Subaran SS; Yang D; Lakatta EG; Lin L
PLoS One; 2012; 7(12):e50736. PubMed ID: 23284645
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
7. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the soluble receptor for advanced glycation end products (sRAGE).
Sárkány Z; Ikonen TP; Ferreira-da-Silva F; Saraiva MJ; Svergun D; Damas AM
J Biol Chem; 2011 Oct; 286(43):37525-34. PubMed ID: 21865159
[TBL] [Abstract][Full Text] [Related]
9. Intertwined structured and unstructured regions of exRAGE identified by monitoring hydrogen-deuterium exchange.
Kupniewska-Kozak A; Gospodarska E; Dadlez M
J Mol Biol; 2010 Oct; 403(1):52-65. PubMed ID: 20732329
[TBL] [Abstract][Full Text] [Related]
10. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for ligand recognition and activation of RAGE.
Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1.
Rai V; Maldonado AY; Burz DS; Reverdatto S; Yan SF; Schmidt AM; Shekhtman A
J Biol Chem; 2012 Feb; 287(7):5133-44. PubMed ID: 22194616
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
14. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
[TBL] [Abstract][Full Text] [Related]
15. N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth.
Srikrishna G; Huttunen HJ; Johansson L; Weigle B; Yamaguchi Y; Rauvala H; Freeze HH
J Neurochem; 2002 Mar; 80(6):998-1008. PubMed ID: 11953450
[TBL] [Abstract][Full Text] [Related]
16. Stable RAGE-heparan sulfate complexes are essential for signal transduction.
Xu D; Young JH; Krahn JM; Song D; Corbett KD; Chazin WJ; Pedersen LC; Esko JD
ACS Chem Biol; 2013 Jul; 8(7):1611-20. PubMed ID: 23679870
[TBL] [Abstract][Full Text] [Related]
17. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.
Sirois CM; Jin T; Miller AL; Bertheloot D; Nakamura H; Horvath GL; Mian A; Jiang J; Schrum J; Bossaller L; Pelka K; Garbi N; Brewah Y; Tian J; Chang C; Chowdhury PS; Sims GP; Kolbeck R; Coyle AJ; Humbles AA; Xiao TS; Latz E
J Exp Med; 2013 Oct; 210(11):2447-63. PubMed ID: 24081950
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of RAGE: roles in biology and disease.
Kalea AZ; Schmidt AM; Hudson BI
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2756-70. PubMed ID: 21622207
[TBL] [Abstract][Full Text] [Related]
19. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
20. RAGE: a single receptor fits multiple ligands.
Fritz G
Trends Biochem Sci; 2011 Dec; 36(12):625-32. PubMed ID: 22019011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
